Pharmacokinetics of a single dose of ceftaroline [ceftaroline-fosamil] in subjects 12 to 17 years of age receiving empiric parenteral antibiotic therapy for suspected infections

Trial Profile

Pharmacokinetics of a single dose of ceftaroline [ceftaroline-fosamil] in subjects 12 to 17 years of age receiving empiric parenteral antibiotic therapy for suspected infections

Completed
Phase of Trial: Phase I

Latest Information Update: 16 Mar 2017

At a glance

  • Drugs Ceftaroline fosamil (Primary)
  • Indications Bacterial infections
  • Focus Pharmacokinetics
  • Sponsors Cerexa; Forest Laboratories
  • Most Recent Events

    • 21 Sep 2015 Pooled analysis results from this trial and other 4 trials presented at the Joint 55th Interscience Conference on Antimicrobial Agents and Chemotherapy and 28th International Congress of Chemotherapy.
    • 01 Feb 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 16 Jun 2008 Status changed from initiated to recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top